Ca2+/calmodulin-dependent protein kinase II-γ (CaMKIIγ) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling

FASEB Journal

Volumn 30, Issue 3, 2016, Pages 1051-1064

  Saddouk, Fatima Z ^a   Sun, Li Yan ^a   Liu, Yong Feng ^a   Jiang, Miao ^a   Singer, Diane V ^a   Backs, Johannes ^b   Van Riper, Dee ^a   Ginnan, Roman ^a   Schwarz, John J ^a   Singer, Harold A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Camk2d; Camk2g; Restenosis

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II GAMMA; MESSENGER RNA; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADENOVIRIDAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAROTID ARTERY; CAROTID ARTERY LIGATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE DELIVERY SYSTEM; GENE TRANSFER; MALE; MOLECULAR DYNAMICS; MOUSE; NEOINTIMA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; CELL LINE; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; BIOMARKERS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CAROTID ARTERIES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR REMODELING;

EID: 84963964049     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-279158     Document Type: Article

References (68)

1. Yoshida, T., and Owens, G. K. (2005) Molecular determinants of vascular smooth muscle cell diversity. Circ. Res. 96, 280-291
2. Singer, H. A. (2012) Ca2+/calmodulin-dependent protein kinase II function in vascular remodelling. J. Physiol. 590, 1349-1356
3. Wamhoff, B. R., Bowles, D. K., and Owens, G. K. (2006) Excitation-transcription coupling in arterial smooth muscle. Circ. Res. 98, 868-878
4. Marganski, W. A., Gangopadhyay, S. S., Je, H. D., Gallant, C., and Morgan, K. G. (2005) Targeting of a novel Ca+2/calmodulindependent protein kinase II is essential for extracellular signalregulated kinase-mediated signaling in differentiated smooth muscle cells. Circ. Res. 97, 541-549
5. Rokolya, A., and Singer, H. A. (2000) Inhibition of CaM kinase II activation and force maintenance by KN-93 in arterial smooth muscle. Am. J. Physiol. Cell Physiol. 278, C537-C545
6. Tombes, R.M., Faison, M.O., and Turbeville, J.M.(2003) Organization and evolution of multifunctional Ca(2+)/CaM-dependent protein kinase genes. Gene 322, 17-31
7. Schworer, C. M., Rothblum, L. I., Thekkumkara, T. J., and Singer, H. A. (1993) Identification of novel isoforms of the delta subunit of Ca2+/calmodulin-dependent protein kinase II: differential expression in rat brain and aorta. J. Biol. Chem. 268, 14443-14449
8. Singer, H. A., Benscoter, H. A., and Schworer, C. M. (1997) Novel Ca2+/calmodulin-dependent protein kinase II gamma-subunit variants expressed in vascular smooth muscle, brain, and cardiomyocytes. J. Biol. Chem. 272, 9393-9400
9. Srinivasan, M., Edman, C. F., and Schulman, H. (1994) Alternative splicing introduces a nuclear localization signal that targets multifunctional CaMkinase to the nucleus. J. Cell Biol. 126, 839-852
10. O'Leary, H., Lasda, E., and Bayer, K. U. (2006) CaMKIIbeta association with the actin cytoskeleton is regulated by alternative splicing. Mol. Biol. Cell 17, 4656-4665
11. Ginnan, R., Zou, X., Pfleiderer, P. J., Mercure, M. Z., Barroso, M., and Singer, H. A. (2013) Vascular smooth muscle cell motility is mediated by a physical and functional interaction of Ca2+/calmodulin-dependent protein kinase IIδ2 and Fyn. J. Biol. Chem. 288, 29703-29712
12. House, S. J., and Singer, H. A. (2008) CaMKII-delta isoform regulation of neointima formation after vascular injury. Arterioscler. Thromb. Vasc. Biol. 28, 441-447
13. House, S. J., Ginnan, R.G., Armstrong, S. E., and Singer, H.A. (2007) Calcium/calmodulin-dependent protein kinase II-delta isoform regulation of vascular smooth muscle cell proliferation. Am. J. Physiol. Cell Physiol. 292, C2276-C2287
14. Li, W., Li, H., Sanders, P. N., Mohler, P. J., Backs, J., Olson, E. N., Anderson, M. E., and Grumbach, I. M. (2011) The multifunctional Ca2+/calmodulin-dependent kinase II delta (CaMKIIdelta) controls neointima formation after carotid ligation and vascular smooth muscle cell proliferation through cell cycle regulation by p21. J. Biol. Chem. 286, 7990-7999
15. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. (1998) A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95, 2509-2514
16. Long, X., Bell, R. D., Gerthoffer, W. T., Zlokovic, B. V., and Miano, J. M. (2008) Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arterioscler. Thromb. Vasc. Biol. 28, 1505-1510
17. Streb, J.W., and Miano, J.M. (2005) AKAP12alpha, an atypical serum response factor-dependent target gene. J. Biol. Chem. 280, 4125-4134
18. O'Carroll, S. J., Hall, A. R., Myers, C. J., Braithwaite, A. W., and Dix, B. R. (2000) Quantifying adenoviral titers by spectrophotometry. Biotechniques 28, 408-410, 412
19. Backs, J., Backs, T., Neef, S., Kreusser, M. M., Lehmann, L. H., Patrick, D. M., Grueter, C. E., Qi, X., Richardson, J. A., Hill, J. A., Katus, H. A., Bassel-Duby, R., Maier, L. S., and Olson, E. N. (2009) The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc. Natl. Acad. Sci. USA 106, 2342-2347
20. Backs, J., Stein, P., Backs, T., Duncan, F. E., Grueter, C.E., McAnally, J., Qi, X., Schultz, R.M., and Olson, E.N. (2010) The gamma isoform of CaM kinase II controls mouse egg activation by regulating cell cycle resumption. Proc. Natl. Acad. Sci. USA 107, 81-86
21. Geisterfer, A.A., Peach, M. J., and Owens, G.K. (1988) Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62, 749-756
22. Kumar, A., and Lindner, V. (1997) Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol. 17, 2238-2244
23. Huang, J., Cheng, L., Li, J., Chen, M., Zhou, D., Lu, M.M., Proweller, A., Epstein, J. A., and Parmacek, M. S. (2008) Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice. J. Clin. Invest. 118, 515-525
24. Wang, D., Chang, P. S., Wang, Z., Sutherland, L., Richardson, J. A., Small, E., Krieg, P. A., and Olson, E. N. (2001) Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105, 851-862
25. Mancarella, S., Potireddy, S., Wang, Y., Gao, H., Gandhirajan, R. K., Autieri, M., Scalia, R., Cheng, Z., Wang, H., Madesh, M., Houser, S. R., and Gill, D. L. (2013) Targeted STIM deletion impairs calcium homeostasis, NFAT activation, and growth of smooth muscle. FASEB J. 27, 893-906
26. Leeper, N. J., Raiesdana, A., Kojima, Y., Chun, H. J., Azuma, J., Maegdefessel, L., Kundu, R. K., Quertermous, T., Tsao, P. S., and Spin, J. M. (2011) MicroRNA-26α is a novel regulator of vascular smooth muscle cell function. J. Cell. Physiol. 226, 1035-1043
27. Althoff, T. F., Albarrán Juárez, J., Troidl, K., Tang, C., Wang, S., Wirth, A., Takefuji, M., Wettschureck, N., and Offermanns, S. (2012) Procontractile G protein-mediated signaling pathways antagonistically regulate smooth muscle differentiation in vascular remodeling. J. Exp. Med. 209, 2277-2290
28. Yang, Y., Zhu, W. Z., Joiner, M. L., Zhang, R., Oddis, C. V., Hou, Y., Yang, J., Price, E. E., Gleaves, L., Eren, M., Ni, G., Vaughan, D. E., Xiao, R. P., and Anderson, M. E. (2006) Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am. J. Physiol. Heart Circ. Physiol. 291, H3065-H3075
29. Zhu, W., Woo, A. Y., Yang, D., Cheng, H., Crow, M.T., and Xiao, R.P. (2007) Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J. Biol. Chem. 282, 10833-10839
30. Skelding, K. A., Rostas, J. A., and Verrills, N. M. (2011) Controlling the cell cycle: the role of calcium/calmodulin-stimulated protein kinases I and II. Cell Cycle 10, 631-639
31. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997) Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299
32. Lu, X. (2010) Tied up in loops: positive and negative autoregulation of p53. Cold Spring Harb. Perspect. Biol. 2, a000984
33. Mayo, L. D., and Donner, D. B. (2001) A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. USA 98, 11598-11603
34. Zhou, B. P., Liao, Y., Xia, W., Zou, Y., Spohn, B., and Hung, M. C. (2001) HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3, 973-982
35. Scott, J. A., Xie, L., Li, H., Li, W., He, J.B., Sanders, P. N., Carter, A. B., Backs, J., Anderson, M. E., and Grumbach, I. M. (2012) The multifunctional Ca2+/calmodulin-dependent kinase II regulates vascular smooth muscle migration through matrix metalloproteinase 9. Am. J. Physiol. Heart Circ. Physiol. 302, H1953-H1964
36. Li, H., Li, W., Gupta, A. K., Mohler, P. J., Anderson, M. E., and Grumbach, I. M. (2010) Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 298, H688-H698
37. Aubart, F. C., Sassi, Y., Coulombe, A., Mougenot, N., Vrignaud, C., Leprince, P., Lechat, P., Lompré, A.M., and Hulot, J. S. (2009) RNA interference targeting STIM1 suppresses vascular smooth muscle cell proliferation and neointima formation in the rat. Mol. Ther. 17, 455-462
38. Lipskaia, L., del Monte, F., Capiod, T., Yacoubi, S., Hadri, L., Hours, M., Hajjar, R. J., and Lompré, A. M. (2005) Sarco/endoplasmic reticulum Ca2+- ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat. Circ. Res. 97, 488-495
39. Liu, Z., Zhang, C., Dronadula, N., Li, Q., and Rao, G. N. (2005) Blockade of nuclear factor of activated T cells activation signaling suppresses balloon injury-induced neointima formation in a rat carotid artery model. J. Biol. Chem. 280, 14700-14708
40. Potier, M., Gonzalez, J. C., Motiani, R. K., Abdullaev, I. F., Bisaillon, J.M., Singer, H. A., and Trebak, M. (2009) Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J. 23, 2425-2437
41. Zhang, W., Halligan, K. E., Zhang, X., Bisaillon, J. M., Gonzalez-Cobos, J. C., Motiani, R. K., Hu, G., Vincent, P. A., Zhou, J., Barroso, M., Singer, H. A., Matrougui, K., and Trebak, M. (2011) Orai1-mediated I (CRAC) is essential for neointima formation after vascular injury. Circ. Res. 109, 534-542
42. Kreusser, M. M., Lehmann, L. H., Keranov, S., Hoting, M. O., Oehl, U., Kohlhaas, M., Reil, J. C., Neumann, K., Schneider, M. D., Hill, J. A., Dobrev, D., Maack, C., Maier, L. S., Gröne, H. J., Katus, H. A., Olson, E. N., and Backs, J. (2014) Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy. Circulation 130, 1262-1273
43. Weinreuter, M., Kreusser, M. M., Beckendorf, J., Schreiter, F. C., Leuschner, F., Lehmann, L. H., Hofmann, K. P., Rostosky, J. S., Diemert, N., Xu, C., Volz, H.C., Jungmann, A., Nickel, A., Sticht, C., Gretz, N., Maack, C., Schneider, M. D., Gröne, H. J., Müller, O. J., Katus, H. A., and Backs, J. (2014) CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury. EMBO Mol. Med. 6, 1231-1245
44. Zhang, M., Hagenmueller, M., Riffel, J. H., Kreusser, M. M., Bernhold, E., Fan, J., Katus, H. A., Backs, J., and Hardt, S. E. (2015) Calcium/calmodulin-dependent protein kinase II couples Wnt signaling with histone deacetylase 4 andmediates dishevelled-induced cardiomyopathy. Hypertension 65, 335-344
45. Kitchen, C. M., Cowan, S. L., Long, X., and Miano, J. M. (2013) Expression and promoter analysis of a highly restricted integrin alpha gene in vascular smooth muscle. Gene 513, 82-89
46. 2+/calmodulin-dependent kinase IId (CaMKIId) regulates arteriogenesis in a mouse model of flow-mediated remodeling. PLoS One 8, e71550
47. Zhu, L. J., Klutho, P. J., Scott, J. A., Xie, L., Luczak, E. D., Dibbern, M. E., Prasad, A.M., Jaffer, O. A., Venema, A. N., Nguyen, E. K., Guan, X., Anderson, M. E., and Grumbach, I. M. (2014) Oxidative activation of the Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis. Vascul. Pharmacol. 60, 75-83
48. Abraham, S. T., Benscoter, H., Schworer, C. M., and Singer, H. A. (1996) In situ Ca2+ dependence for activation of Ca2+/calmodulindependent protein kinase II in vascular smooth muscle cells. J. Biol. Chem. 271, 2506-2513
49. Wu, X., Zou, Y., Zhou, Q., Huang, L., Gong, H., Sun, A., Tateno, K., Katsube, K., Radtke, F., Ge, J., Minamino, T., and Komuro, I. (2011) Role of Jagged1 in arterial lesions after vascular injury. Arterioscler. Thromb. Vasc. Biol. 31, 2000-2006
50. Furgeson, S. B., Simpson, P. A., Park, I., Vanputten, V., Horita, H., Kontos, C. D., Nemenoff, R. A., and Weiser-Evans, M. C. (2010) Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovasc. Res. 86, 274-282
51. Roque, M., Fallon, J. T., Badimon, J. J., Zhang, W. X., Taubman, M. B., and Reis, E. D. (2000) Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler. Thromb. Vasc. Biol. 20, 335-342
52. Majesky, M.W., Dong, X. R., Regan, J.N., and Hoglund, V. J. (2011) Vascular smooth muscle progenitor cells: building and repairing blood vessels. Circ. Res. 108, 365-377
53. Yun, J., Chae, H. D., Choy, H. E., Chung, J., Yoo, H. S., Han, M.H., and Shin, D. Y. (1999) p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J. Biol. Chem. 274, 29677-29682
54. Taylor, W. R., and Stark, G. R. (2001) Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815
55. Kidokoro, T., Tanikawa, C., Furukawa, Y., Katagiri, T., Nakamura, Y., and Matsuda, K. (2008) CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene 27, 1562-1571
56. Taylor, W. R., Schonthal, A. H., Galante, J., and Stark, G. R. (2001) p130/E2F4 binds to and represses the cdc2 promoter in response to p53. J. Biol. Chem. 276, 1998-2006
57. Krause, K., Haugwitz, U., Wasner, M., Wiedmann, M., Mössner, J., and Engeland, K. (2001) Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73. Biochem. Biophys. Res. Commun. 284, 743-750
58. Agarwal, M. L., Agarwal, A., Taylor, W.R., and Stark, G.R. (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92, 8493-8497
59. Saha, K., Adhikary, G., Kanade, S. R., Rorke, E. A., and Eckert, R. L. (2014) p38d regulates p53 to control p21Cip1 expression in human epidermal keratinocytes. J. Biol. Chem. 289, 11443-11453
60. Hayashi, S., Morishita, R., Matsushita, H., Nakagami, H., Taniyama, Y., Nakamura, T., Aoki, M., Yamamoto, K., Higaki, J., and Ogihara, T. (2000) Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. Hypertension 35, 237-243
61. Gaertner, T. R., Kolodziej, S. J., Wang, D., Kobayashi, R., Koomen, J.M., Stoops, J. K., and Waxham, M. N. (2004) Comparative analyses of the three-dimensional structures and enzymatic properties of alpha, beta, gamma and delta isoforms of Ca2+-calmodulindependent protein kinase II. J. Biol. Chem. 279, 12484-12494
62. Liu, Y., Sun, L. Y., Singer, D.V., Ginnan, R., and Singer, H. A. (2013) CaMKIIδ-dependent inhibition of cAMP-response element-binding protein activity in vascular smooth muscle. J. Biol. Chem. 288, 33519-33529
63. 2+/CaMto the nucleus to trigger CREB phosphorylation and gene expression. Cell 159, 281-294
64. Gray, C. B., and Heller Brown, J. (2014) CaMKIIdelta subtypes: localization and function. Front. Pharmacol. 5, 15
65. Zhang, T., Kohlhaas, M., Backs, J., Mishra, S., Phillips, W., Dybkova, N., Chang, S., Ling, H., Bers, D. M., Maier, L. S., Olson, E. N., and Brown, J. H. (2007) CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J. Biol. Chem. 282, 35078-35087
66. Saura, M., Marquez, S., Reventun, P., Olea-Herrero, N., Arenas, M. I., Moreno-Gómez-Toledano, R., Gómez-Parrizas, M., Muñóz-Moreno, C., González-Santander, M., Zaragoza, C., and Bosch, R. J. (2014) Oral administration of bisphenol A induces high blood pressure through angiotensin II/CaMKII-dependent uncoupling of eNOS. FASEB J. 28, 4719-4728
67. Deanfield, J. E., Halcox, J. P., and Rabelink, T. J. (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115, 1285-1295
68. Majesky, M. W. (2007) Developmental basis of vascular smooth muscle diversity. Arterioscler. Thromb. Vasc. Biol. 27, 1248-1258